A retrospective investigation of the platelet-to-lymphocyte ratio as a potential indicator in early rheumatoid arthritis
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Background The platelet-to-lymphocyte ratio (PLR) has been suggested as a biomarker for inflammation and disease activity in rheumatoid arthritis (RA). However, current findings on its correlation with the Disease Activity Score 28 (DAS28) remain inconsistent. This study aimed to explore the correlation between PLR and DAS28. Methods This retrospective study analyzed 433 consecutive inpatients with early RA at Xingtai People’s Hospital between January 2022 and January 2024. Of these, 72.06% were women, with a mean age of 52.52 ± 14.20 years. All patients met the 2010 American College of Rheumatology/European League Against Rheumatism criteria and had symptoms
Fields of Study & Subjects
Inflammatory Biomarkers in Disease Prognosis
Rheumatoid Arthritis Research and Therapies
Autoimmune and Inflammatory Disorders Research
Publication details
- Journal / source
- PeerJ
- Volume
- 14
- Pages
- e21004–e21004
- Publication date
- 31 March 2026
- Language
- EN